Rad Onc Twitter

Started by deleted1002574
This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Get help with your application

Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.

University nonprofits etc are outrageous, but don't forget the elephant(s) in the room.

UnitedHealthcare for example. Has about $450B in annual revenue. About $200B of that comes from CMS, and $100B from state Medicaid programs.

UHC is "free" to do whatever it wants or thinks best in the "free market," but we are not "free" from paying taxes to support them.

Like the Comedian said "It's all a joke."

3.14% profit margin though for UHC. Lower than hospital systems, which are usually around 5-6%. Lower than (hopefully for the owners) that of private practice groups.

The revenue numbers are impressive but the profit margins are not.
 
Advertisement - Members don't see this ad
3.14% profit margin though for UHC. Lower than hospital systems, which are usually around 5-6%. Lower than (hopefully for the owners) that of private practice groups.

The revenue numbers are impressive but the profit margins are not.
keep in mind how most insurance products work. The employer pays with united acting as the middleman/handling the transaction. it would be like concluding that Codwell bankers revenue is the total of their house sales.
 
1789107823377.png


When was the last time you interrupted treatment due to skin toxicity in breast cancer?

I can't remember...
 
View attachment 424429

When was the last time you interrupted treatment due to skin toxicity in breast cancer?

I can't remember...
Patient: "Why is my skin all red and peeling? I thought protons had less side effects??"

MD Anderson: "Oh no, the skin reaction just means the protons are working!"

Patient <smiles> and proceeds to take a picture of her skin for Instagram

--------

This was actual concluding paragraph of the trial:

In conclusion, acute adverse effects following breast RT were predominantly skin-related. PT was associated with higher rates of grades 2-3 dermatitis, pruritus, and pain than γRT; however, these effects were transient, largely reversible, and did not result in treatment discontinuation. Nonskin-related side effects were comparable between treatment groups. The higher incidence of acute skin side effects following PT should be considered in the context of its dosimetric advantages, particularly the reduced dose to OAR. These findings highlight the importance of balancing the expected dosimetric benefits against the risk of increased acute skin toxicity when selecting patients for PT.

In other words, protons caused demonstrably worse skin toxicity in a manner that was highly statistically significant. However, you should still consider protons for breasts due to the "expected dosimetric benefits."

If you are going to go through the trouble of creating, enrolling patients on, and publishing a randomized trial that is negative, and you still reach this conclusion . . . what, pray tell, was the purpose of the trial in the first place?
 
Last edited:
View attachment 424429

When was the last time you interrupted treatment due to skin toxicity in breast cancer?

I can't remember...
Heard a proton therapist say it was almost one in two of their proton breast patients … I have never witnessed with my own eyes proton breast RT effects. So solipsistically speaking I should maybe still be skeptical protons are worse than photons.
 
Everyone is right to bash on the conclusion of the trial and the way things are written, but I will say the proton centers I'm familiar with specifically contour and modulate the dose to the skin. I'm not sure if that was done on this trial and I can imagine that making a difference on this particular finding.

The broader conclusion to me is that photons have gotten so good we're not really finding clinically significant differences despite the dosimetric differences
 
but I will say the proton centers I'm familiar with specifically contour and modulate the dose to the skin.
You mean, they treat the skin like an OAR...
But I thought protons have "dosimetric advantages, particularly the reduced dose to OAR"

Ok, I'm just trolling now...
 
Everyone is right to bash on the conclusion of the trial and the way things are written, but I will say the proton centers I'm familiar with specifically contour and modulate the dose to the skin. I'm not sure if that was done on this trial and I can imagine that making a difference on this particular finding.

The broader conclusion to me is that photons have gotten so good we're not really finding clinically significant differences despite the dosimetric differences
At a fraction of the price. Sounds like photons should be the standard of care
 
Advertisement - Members don't see this ad
Everyone is right to bash on the conclusion of the trial and the way things are written, but I will say the proton centers I'm familiar with specifically contour and modulate the dose to the skin. I'm not sure if that was done on this trial and I can imagine that making a difference on this particular finding.

The broader conclusion to me is that photons have gotten so good we're not really finding clinically significant differences despite the dosimetric differences
I mean yes, it's done now, after we learned that people's skin really lit up (especially during the old PS days). The point is that we're treating patients with protons for breast/prostate just to get to the point where we can say they're "another possible option," not that they're actually better. Yes, you can argue that learning/developing these technologies is useful work, but if that were the primary motivation, I imagine I'd see fewer claims about "lower side effects."
 
Patient: "Why is my skin all red and peeling? I thought protons had less side effects??"

MD Anderson: "Oh no, the skin reaction just means the protons are working!"

Patient <smiles> and proceeds to take a picture of her skin for Instagram

--------

This was actual concluding paragraph of the trial:



In other words, protons caused demonstrably worse skin toxicity in a manner that was highly statistically significant. However, you should still consider protons for breasts due to the "expected dosimetric benefits."

If you are going to go through the trouble of creating, enrolling patients on, and publishing a randomized trial that is negative, and you still reach this conclusion . . . what, pray tell, was the purpose of the trial in the first place?

They had that conclusion written long before the trial started enrolling
 
Last edited:
In my experience HIPAA only applies when one doctors office is trying to obtain relevant and necessary patient information from another doctors office. Otherwise let the AI bots scrape whatever it is they may need.
 
Everyone is right to bash on the conclusion of the trial and the way things are written, but I will say the proton centers I'm familiar with specifically contour and modulate the dose to the skin. I'm not sure if that was done on this trial and I can imagine that making a difference on this particular finding.

The broader conclusion to me is that photons have gotten so good we're not really finding clinically significant differences despite the dosimetric differences
Whenever protons have a bad effect, someone points out that nowadays they are being delivered differently. Pencil beam, robustness, etc. I have never heard of a rib fracture from photons in breast cancer.

has anyone at a proton center pulled a Nicole Hannah jones and had themselves or a family member treated with protons?
 
Last edited:


Here is John Oliver, ranting about everyone's favorite pinata United Healthcare. Fast forward to 12:45 and you will find an interesting case where a woman had recurrent cervical cancer that her doctors at Harvard wanted to treat with proton beam. This was back in 2018.

From what I could gather from the article she initially had locally advanced disease, was treated with chemorads and had a recurrence in the PA lymph nodes. MGH wanted protons to treat it and UHC refused. She ultimately scrounged $95,000 to pay for it out of pocket (~$126,000 in todays USD value adjusted for inflation).

DIscuss.
 


Here is John Oliver, ranting about everyone's favorite pinata United Healthcare. Fast forward to 12:45 and you will find an interesting case where a woman had recurrent cervical cancer that her doctors at Harvard wanted to treat with proton beam. This was back in 2018.

From what I could gather from the article she initially had locally advanced disease, was treated with chemorads and had a recurrence in the PA lymph nodes. MGH wanted protons to treat it and UHC refused. She ultimately scrounged $95,000 to pay for it out of pocket (~$126,000 in todays USD value adjusted for inflation).

DIscuss.


I wouldn't have paid for protons there either, unless the PA nodes were covered as a part of the initial treatment, which I doubt they were.

I treat recurrent disease (usually prostate, but not always) along the PALNs all the time without protons with zero issues. MGH having the family pay cash rather than going with a perfectly-acceptable SBRT plan is morally bankrupt behavior, and they should be ashamed.
 


Here is John Oliver, ranting about everyone's favorite pinata United Healthcare. Fast forward to 12:45 and you will find an interesting case where a woman had recurrent cervical cancer that her doctors at Harvard wanted to treat with proton beam. This was back in 2018.

From what I could gather from the article she initially had locally advanced disease, was treated with chemorads and had a recurrence in the PA lymph nodes. MGH wanted protons to treat it and UHC refused. She ultimately scrounged $95,000 to pay for it out of pocket (~$126,000 in todays USD value adjusted for inflation).

DIscuss.

I think we talked about this back in 2018, maybe even in this thread. I know nothing about the specifics of this case, but I’d feel awful telling the patient they needed to pay 100k for protons for a pa nodal recurrence, barring other factors.

That being said, it's still tough for me to side with United against a physician.
 
Last edited:


Here is John Oliver, ranting about everyone's favorite pinata United Healthcare. Fast forward to 12:45 and you will find an interesting case where a woman had recurrent cervical cancer that her doctors at Harvard wanted to treat with proton beam. This was back in 2018.

From what I could gather from the article she initially had locally advanced disease, was treated with chemorads and had a recurrence in the PA lymph nodes. MGH wanted protons to treat it and UHC refused. She ultimately scrounged $95,000 to pay for it out of pocket (~$126,000 in todays USD value adjusted for inflation).

DIscuss.

You know a wild thing about this story that no one will really ever know and you won’t hear in the news. This decision came down to one low level board certified radiation oncologist working for UHC looking at a computer screen and deciding “no.” There’s really no great UHC conspiracy or anything like that. The one person could have decided yes with no repercussions whatsoever.
 
I wouldn't have paid for protons there either
This reminds me of the OJ Simpson trial. OJ (like United) was guilty of horrific crimes IMO, regarding which the evidence is incontrovertible.

As the lawyers say...never frame a guilty man (thinking Mark Fuhrman in the OJ case, MGH protons in this one).

Somehow protons (our most dubious and expensive intervention) seem to get disproportionate media play regarding the practice of predatory denials...probably because it's a rich person thing.
 
This reminds me of the OJ Simpson trial. OJ (like United) was guilty of horrific crimes IMO, regarding which the evidence is incontrovertible.

As the lawyers say...never frame a guilty man (thinking Mark Fuhrman in the OJ case, MGH protons in this one).

Somehow protons (our most dubious and expensive intervention) seem to get disproportionate media play regarding the practice of predatory denials...probably because it's a rich person thing.
My favorite theory about the OJ Simpson trial is that his son did it and OJ covered for him. His son had known issues and, given the more primitive DNA testing then, he and his son would have been a DNA match...but the glove would not have fit.
 
Advertisement - Members don't see this ad
I am not sure why protons would be better for re-irradiation or pediatrics. I think the logic is that they must have some redemmeing utility and somehow can’t suck for everything. There is no reason they can’t be inferior in every scenario.
 
I am not sure why protons would be better for re-irradiation or pediatrics. I think the logic is that they must have some redemmeing utility and somehow can’t suck for everything. There is no reason they can’t be inferior in every scenario.

Where I used to work at the city academic proton center patients just showed up demanding protons all the time, and if I didn’t give it to them they went elsewhere and got the protons instead. I gave up quickly trying to be rational about it given that I was being paid $/RVU.